Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Bacterial Vaginosis Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Bacterial Vaginosis Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Oral
      • 1.3.3 Topical
    • 1.4 Market Segment by Application
      • 1.4.1 Global Bacterial Vaginosis Drugs Market Share by Application (2019-2025)
      • 1.4.2 Pelvic Inflammatory Disease
      • 1.4.3 Preterm Delivery of Infants
      • 1.4.4 Urinary Tract Infection
      • 1.4.5 Sexually Transmitted Diseases (STD)
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Bacterial Vaginosis Drugs Market Size
      • 2.1.1 Global Bacterial Vaginosis Drugs Revenue 2014-2025
      • 2.1.2 Global Bacterial Vaginosis Drugs Sales 2014-2025
    • 2.2 Bacterial Vaginosis Drugs Growth Rate by Regions
      • 2.2.1 Global Bacterial Vaginosis Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Bacterial Vaginosis Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Bacterial Vaginosis Drugs Sales by Manufacturers
      • 3.1.1 Bacterial Vaginosis Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Bacterial Vaginosis Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Bacterial Vaginosis Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Bacterial Vaginosis Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Bacterial Vaginosis Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Bacterial Vaginosis Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Bacterial Vaginosis Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Bacterial Vaginosis Drugs Market
    • 3.6 Key Manufacturers Bacterial Vaginosis Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Oral Sales and Revenue (2014-2019)
      • 4.1.2 Topical Sales and Revenue (2014-2019)
    • 4.2 Global Bacterial Vaginosis Drugs Sales Market Share by Type
    • 4.3 Global Bacterial Vaginosis Drugs Revenue Market Share by Type
    • 4.4 Bacterial Vaginosis Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Bacterial Vaginosis Drugs Sales by Application

    6 United States

    • 6.1 United States Bacterial Vaginosis Drugs Breakdown Data by Company
    • 6.2 United States Bacterial Vaginosis Drugs Breakdown Data by Type
    • 6.3 United States Bacterial Vaginosis Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Bacterial Vaginosis Drugs Breakdown Data by Company
    • 7.2 European Union Bacterial Vaginosis Drugs Breakdown Data by Type
    • 7.3 European Union Bacterial Vaginosis Drugs Breakdown Data by Application

    8 China

    • 8.1 China Bacterial Vaginosis Drugs Breakdown Data by Company
    • 8.2 China Bacterial Vaginosis Drugs Breakdown Data by Type
    • 8.3 China Bacterial Vaginosis Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Bacterial Vaginosis Drugs Breakdown Data by Company
    • 9.2 Rest of World Bacterial Vaginosis Drugs Breakdown Data by Type
    • 9.3 Rest of World Bacterial Vaginosis Drugs Breakdown Data by Application
    • 9.4 Rest of World Bacterial Vaginosis Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Bacterial Vaginosis Drugs Sales by Countries
      • 9.4.2 Rest of World Bacterial Vaginosis Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Bayer
      • 10.1.1 Bayer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Bacterial Vaginosis Drugs
      • 10.1.4 Bacterial Vaginosis Drugs Product Introduction
      • 10.1.5 Bayer Recent Development
    • 10.2 Pfizer
      • 10.2.1 Pfizer Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Bacterial Vaginosis Drugs
      • 10.2.4 Bacterial Vaginosis Drugs Product Introduction
      • 10.2.5 Pfizer Recent Development
    • 10.3 Sanofi
      • 10.3.1 Sanofi Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Bacterial Vaginosis Drugs
      • 10.3.4 Bacterial Vaginosis Drugs Product Introduction
      • 10.3.5 Sanofi Recent Development
    • 10.4 Starpharma Holdings
      • 10.4.1 Starpharma Holdings Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Bacterial Vaginosis Drugs
      • 10.4.4 Bacterial Vaginosis Drugs Product Introduction
      • 10.4.5 Starpharma Holdings Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Bacterial Vaginosis Drugs Sales Channels
      • 11.2.2 Bacterial Vaginosis Drugs Distributors
    • 11.3 Bacterial Vaginosis Drugs Customers

    12 Market Forecast

    • 12.1 Global Bacterial Vaginosis Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Bacterial Vaginosis Drugs Sales Forecast by Type
    • 12.3 Global Bacterial Vaginosis Drugs Sales Forecast by Application
    • 12.4 Bacterial Vaginosis Drugs Forecast by Regions
      • 12.4.1 Global Bacterial Vaginosis Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Bacterial Vaginosis Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis include the use of probiotics and medication. Common drug classes include lincosamide antibiotics and nitroimidazole antibiotics.
      One driver in the market is unmet demand in BV treatment market. Unmet demand in the treatment of BV has created great opportunity for the market players. There is huge unmet need in the treatment of BV, especially the recurrent form of the disease. BV is the most common vaginal infection in the women of child bearing age group. Despite being highly prevalent in nature, little has been done in the field. When left untreated, it may lead to severe infections, especially in the case of pregnant women such as preterm births. rising awareness about women's health as one of the primary growth factors for the bacterial vaginosis drugs market. Owing to recent advancements in healthcare and the initiatives taken by the government and non-government organizations to increase the awareness about health of women, the demand for pharmaceuticals related to disorders in women will witness a significant increase in the coming years. Additionally, support from government is also a key driver.
      In 2019, the market size of Bacterial Vaginosis Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bacterial Vaginosis Drugs.

      This report studies the global market size of Bacterial Vaginosis Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Bacterial Vaginosis Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Bayer
      Pfizer
      Sanofi
      Starpharma Holdings
      ...

      Market Segment by Product Type
      Oral
      Topical

      Market Segment by Application
      Pelvic Inflammatory Disease
      Preterm Delivery of Infants
      Urinary Tract Infection
      Sexually Transmitted Diseases (STD)

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Bacterial Vaginosis Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Bacterial Vaginosis Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Bacterial Vaginosis Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now